All Companies
Ticker BDRX
We can't reconcile this ticker's share basis yet
You reached the page — here's exactly what BDRX is, and why it's out of scope for now.
What this ticker is
BDRX
Biodexa Pharmaceuticals PLC
NASDAQ
Healthcare
Biotechnology
Why we can't analyze it yet
Data provider – reported cap ($1,430,401) can't be reconciled with SEC filings (likely a foreign/ADR share-basis mismatch); held out until verified
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
share_basis